Sort
53,477 grants matching “addiction”
Chicago WIHS Consortium V (CWC)
$2,209,223Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2016 · AI
Corticostriatal mechanisms of action learning and habit formation
$2,209,057David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,206,889Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2017 · DA
COBRE Center on Opioids and Overdose
$2,205,702Josiah D Rich · Rhode Island Hospital · P20 · FY2022 · GM
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
$2,205,587Phillip O Coffin · Public Health Foundation Enterprises · U01 · FY2020 · DA
NorthStar Node of the Clinical Trials Network
$2,205,580Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2019 · DA
ADMINISTRATIVE CORE
$2,204,916Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2015 · DA
Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking
$2,204,432Stephen S Hecht · University Of Minnesota · P01 · FY2025 · CA
Neuroimaging Analysis Center (NAC)
$2,204,015Ron Kikinis · Brigham And Women'S Hospital · P41 · FY2015 · EB
Targeting transcriptional addiction in fusion-driven sarcoma
$2,203,647David Glenn McFadden · Ut Southwestern Medical Center · UM1 · FY2024 · CA
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,203,646Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2018 · DA
The impact of dyadic processes on smoking and cigarette craving: An experimental investigation of romantic partners and smoking friends
$2,202,321Michael Andrew Sayette · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
A Novel Strategy for Combating Obesity: Reprogramming Neural Circuits
$2,201,819Kay Maxine Tye · Massachusetts Institute Of Technology · DP2 · FY2013 · DK
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
$2,201,443Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2021 · DA
Center for Research Improving Treatment of Drug Abuse
$2,200,704University Of Pennsylvania · P60 · FY2003 · DA
Selective Kv7.2/3 activators for the treatment of neuropathic pain
$2,200,680Armando Signore · Knopp Biosciences, Llc · U44 · FY2021 · NS
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$2,200,084James L. Sorensen · University Of California, San Francisco · UG1 · FY2019 · DA
NIDA CLINICAL TRIALS NETWORK - NYC EAST SIDE NODE
$2,200,000New York University School Of Medicine · U10 · FY2000 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE
$2,200,000University Of Cincinnati · U10 · FY2001 · DA
CLINICAL RESEARCH COOPERATIVE
$2,200,000University Of Pennsylvania · U10 · FY2000 · DA
NIDA CLINICAL TRIALS NETWORK - NYC EAST SIDE NODE
$2,200,000New York University School Of Medicine · U10 · FY2001 · DA
NIDA CLINICAL TRIALS NETWORK - NYC EAST SIDE NODE
$2,200,000New York University School Of Medicine · U10 · FY2002 · DA
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORK
$2,200,000University Of Miami School Of Medicine · U10 · FY2000 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE
$2,200,000University Of Cincinnati · U10 · FY2000 · DA
Promoting Community Wellbeing Through Indigenous Science and Healing
$2,199,999Michael G McDonell · Washington State University · OT2 · FY2024 · DA